XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders’ Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 3,000 $ 81,267,000 $ (66,161,000) $ 15,109,000
Balance (in Shares) at Dec. 31, 2020 3,190,698      
Common Stock issued for directors fees 210,000 210,000
Common Stock issued for directors fees (in Shares) 16,981      
Stock Options exercised
Stock Options exercised (in Shares) 5,122     11,000
Stock Compensation Expense 443,000 $ 443,000
Net Income (loss) 1,627,000 1,627,000
Balance at Dec. 31, 2021 $ 3,000 81,920,000 (64,534,000) 17,389,000
Balance (in Shares) at Dec. 31, 2021 3,212,801      
Common Stock issued for directors fees 216,000 216,000
Common Stock issued for directors fees (in Shares) 27,849      
Common Stock issued in conjunction with reverse split
Common Stock issued in conjunction with reverse split (in Shares) 7,287      
Stock Options exercised (in Shares)      
Stock Compensation Expense 310,000 $ 310,000
Net Income (loss) (1,076,000) (1,076,000)
Balance at Dec. 31, 2022 $ 3,000 $ 82,446,000 $ (65,610,000) $ 16,839,000
Balance (in Shares) at Dec. 31, 2022 3,247,937